JSM 2017 Online Program

Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme

		Tweet
*393 !**	Tue, 8/1/2017, 2:00 PM - 3:50 PM		CC-304
Using Patient-Reported Outcomes to Capture Symptomatic Adverse Events in Cancer Clinical Trials: Challenges and Opportunities — Topic Contributed Papers
Health Policy Statistics Section
Organizer(s): Joseph Cappelleri, Pfizer Inc
Chair(s): Joseph Cappelleri, Pfizer Inc
2:05 PM	Patient-Reporting of Symptomatic Toxicities of Cancer Treatment: Current Progress and Emerging Challenges — Sandra Anne Mitchell, National Cancer Institute
2:25 PM	PRO-CTCAE Implementation in Oncology Clinical Trials: An Industry Perspective — Paivi Miskala, Pfizer Inc
2:45 PM	PRO-CTCAE in Oncology Clinical Trials: a U.S. Regulatory Perspective — Paul Kluetz, U.S. Food and Drug Administration
3:05 PM	Statistical Methods to Analyze PRO-CTCAE Data in Oncology Clinical Trials — Amylou Dueck, Mayo Clinic
3:25 PM	Discussant: Rajeshwari Sridhara, U.S. Food and Drug Administration
3:45 PM	Floor Discussion